Product analysis
Ginkgo Biloba 60 mg keeps the formula focused on ginkgo, with the main compound groups and their proportions disclosed. That detail helps comparison with other ginkgo preparations.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The main ginkgo compound groups are named. Their relative preparation quality remains uncertain.
Ingredient Transparency100
Ingredient amounts, sources and applicable component proportions are clear. That makes serving comparisons easier.
Value For Money40
Value for the ginkgo contribution remains uncertain. Conflicting quantity declarations also limit a dependable serving comparison.
Customer Satisfaction89
Customer ratings are strongly favorable. A large rating pool provides a broader view of customer satisfaction.
Product Focus57
A single botanical keeps the formula focused. Its expected contribution across the intended uses remains limited rather than broadly established.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.09
- Also available
Ginkgo Biloba 60 mg$6.99- Customer rating
- 4.8 · 3,877 ratings
Goals
Ginkgo provides targeted support for the circulation-related side of cognitive function. The saved serving assessment treats the declared material as an unidentified preparation, so its evidence is less specific than that for a matched trial extract.
How this product is rated for Cognitive Support
Ingredient fit94
Goal fit
Dose adequacy
Pathways40
Depth
Breadth
Evidence25
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ginkgo provides a limited, situation-dependent contribution in the supplied brain-health assessment, centered on energy processes. The declared total includes different ginkgo materials, so a larger total should not be read as greater cognitive benefit.
How this product is rated for Brain Health
Ingredient fit94
Goal fit
Dose adequacy
Pathways43
Depth
Breadth
Evidence58
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ginkgo has inconsistent findings for attention, concentration and memory. The supplied 260 mg total does not establish a dependable everyday productivity benefit, and a larger amount should not be read as greater effectiveness.
How this product is rated for Productivity Boost
Ingredient fit94
Goal fit
Dose adequacy
Pathways13
Depth
Breadth
Evidence53
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
The saved declaration totals 260 mg of ginkgo. Ginkgo has a possible attention-related role, but findings are mixed and declared mass alone does not establish equivalence to a particular extract or a stronger immediate effect.
How this product is rated for Mental Focus
Ingredient fit94
Goal fit
Dose adequacy
Pathways44
Depth
Breadth
Evidence62
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ginkgo extract (Ginkgoflavonglycosides, Terpene Lactones) | 60 mg | |
Ginkgo powder | 200 mg |
How this ingredient is rated
Composition and Label Disclosure10
Marker and Preparation Disclosure
Declared Ginkgolic Acid Limit
Composition and Label Disclosure100
Individual Preparation Amount Disclosure
Commercial Price and Usability
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
- Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
- Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
- Ginkgo biloba in the Aging Process: A Narrative Review.
- [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
- Dietary Flavonoids and Human Cognition: A Meta-Analysis.
- Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.